ロード中...
KSHV Targeted Therapy: An Update on Inhibitors of Viral Lytic Replication
Kaposi’s sarcoma-associated herpesvirus (KSHV) is the causative agent of Kaposi’s sarcoma, primary effusion lymphoma and multicentric Castleman’s disease. Since the discovery of KSHV 20 years ago, there is still no standard treatment and the management of virus-associated malignancies remains toxic...
保存先:
| 出版年: | Viruses |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4246246/ https://ncbi.nlm.nih.gov/pubmed/25421895 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v6114731 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|